Surgical Robotics Uptake: Cutting Through the COVID-19 Noise

article image

Sales and placements of surgical robotic systems took a near-term hit during the early days of the pandemic, but the rebound has been surprisingly strong, and companies continue to invest in the field aggressively.

In the noisy environment surrounding pandemic-driven market data, sorting out financially stressed hospitals’ appetite for investing in expensive technologies is tough.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: